Bioregenx annual debt-to-assets ratio
2021
2022
2023
2024
2025
Bioregenx Debt-to-Assets Ratio Growth & History (BRGX)
Bioregenx's debt-to-assets ratio was 2.88 for fiscal 2025.
View full Bioregenx company overviewBioregenx annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 2.88 | 0.65 | +28.86% |
| 2024 | 2024-12-31 | 2.24 | 2.01 | +868.58% |
| 2023 | 2023-12-31 | 0.23 | −3.15 | −93.17% |
| 2022 | 2022-12-31 | 3.38 | 1.82 | +116.00% |
| 2021 | 2021-12-31 | 1.57 | — | — |
Bioregenx quarterly debt-to-assets ratio
Q4.21
Q1.23
Q4.23
Q1.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | 6.42 | 1.94 | +43.20% |
| Q4 2025 | 2025-12-31 | 2.88 | 0.65 | +28.86% |
| Q3 2025 | 2025-09-30 | 1.93 | — | — |
| Q2 2025 | 2025-06-30 | 1.89 | — | — |
| Q1 2025 | 2025-03-31 | 4.49 | 4.46 | +15087.88% |
| Q4 2024 | 2024-12-31 | 2.24 | 2.01 | +868.58% |
| Q1 2024 | 2024-03-31 | 0.03 | −2.53 | −98.85% |
| Q4 2023 | 2023-12-31 | 0.23 | — | — |
| Q1 2023 | 2023-03-31 | 2.56 | — | — |
| Q4 2021 | 2021-12-31 | 1.57 | — | — |
Bioregenx debt-to-assets ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Bioregenx's debt-to-assets ratio increased from 1.57 to 2.88, a change of 1.32. The latest reported quarter, Q1 2026, shows 6.42.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioregenx source filings ↗